CIK 0001662579
- Non-accelerated filer
- Smaller reporting company
C4 Therapeutics, Inc.
Sign in to watch- Ticker
- CCCC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 475617627
- Phone
- +1 617-231-0700
- Business address
- 490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $122,487
- in 1 filing, $122K under 10b5-1 plans
Net −$122,487. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-14 | Boyle Scott N Chief Business Officer | Option exercise | +20,950 | 306,070 | ||
| 2026-02-14 | Boyle Scott N Chief Business Officer | Shares withheld for taxes | −7,269 | $1.89 | $14K | 298,801 |
| 2026-02-13 | Boyle Scott N Chief Business Officer | Grant or award | +200,000 | 307,805 | ||
| 2026-02-13 | Boyle Scott N Chief Business Officer | Option exercise | +5,000 | 307,805 | ||
| 2026-02-13 | Boyle Scott N Chief Business Officer | Shares withheld for taxes | −1,735 | $1.89 | $3K | 306,070 |
| 2025-02-18 | Boyle Scott N Chief Business Officer | Sale 10b5-1 | −669 | $3.15 | $2K | 107,805 |
| 2025-02-14 | Boyle Scott N Chief Business Officer | Grant or award 10b5-1 | +56,500 | 111,332 | ||
| 2025-02-14 | Boyle Scott N Chief Business Officer | Sale 10b5-1 | −490 | $3.15 | $2K | 110,842 |
| 2025-02-14 | Boyle Scott N Chief Business Officer | Shares withheld for taxes 10b5-1 | −2,368 | $3.18 | $8K | 108,474 |
| 2025-02-14 | Boyle Scott N Chief Business Officer | Grant or award · Stock Option (Right to Buy) 10b5-1 | +84,700 | 84,700 | ||
| 2025-02-13 | Boyle Scott N Chief Business Officer | Shares withheld for taxes 10b5-1 | −1,735 | $3.20 | $6K | 54,832 |
| 2024-11-07 | Boyle Scott N Chief Business Officer | Option exercise | +3,750 | 57,669 | ||
| 2024-11-07 | Boyle Scott N Chief Business Officer | Shares withheld for taxes | −1,102 | $6.04 | $7K | 56,567 |
| 2024-11-07 | Boyle Scott N Chief Business Officer | Option exercise · Performance Restricted Stock Units | −3,750 | 10,500 | ||
| 2024-09-16 | Boyle Scott N Chief Business Officer | Option exercise | +2,250 | 54,580 | ||
| 2024-09-16 | Boyle Scott N Chief Business Officer | Shares withheld for taxes | −661 | $6.36 | $4K | 53,919 |
| 2024-09-16 | Boyle Scott N Chief Business Officer | Option exercise · Performance Restricted Stock Units | −2,250 | 14,250 | ||
| 2024-03-07 | Boyle Scott N Chief Business Officer | Returned to the company · Stock Option (Right to Buy) | −115,000 | 0 | ||
| 2024-03-07 | Boyle Scott N Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +115,000 | 115,000 | ||
| 2024-02-14 | Boyle Scott N Chief Business Officer | Grant or award | +27,300 | 52,330 |
Page 1 of 2 · 34 trades